Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. (Record no. 22139965)

MARC details
000 -LEADER
fixed length control field 01615 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516113248.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201212s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2141
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/bjh.12036
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Else, Monica
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121218
245 00 - TITLE STATEMENT
Title Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of haematology
Date of publication, distribution, etc. Nov 2012
300 ## - PHYSICAL DESCRIPTION
Extent 322-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, B-Cell, Marginal Zone
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Splenic Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marín-Niebla, Ana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de la Cruz, Fátima
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Batty, Paul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ríos, Eduardo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dearden, Claire E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Catovsky, Daniel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matutes, Estella
773 0# - HOST ITEM ENTRY
Title British journal of haematology
Related parts vol. 159
-- no. 3
-- p. 322-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/bjh.12036">https://doi.org/10.1111/bjh.12036</a>
Public note Available from publisher's website

No items available.